Robotic process automation software maker UiPath files to go public on the NYSE, reports $607.M revenue in FY2021, up 81% YoY, and net loss of $92.3M
- UiPath filed with the Securities and Exchange Commission to list on the New York Stock Exchange under the ticker symbol PATH.
Context & Ripple Effects
UiPath's public filing converts a quiet process into an open one: the company had already confidentially filed for an IPO in December off a $10.2B July private valuation, and today's disclosure of $607.0M FY2021 revenue growing 81% YoY is the document that lets public-market investors price it for the first time.
The loss of $92.3M against hypergrowth frames the pitch — land automation customers fast, monetize later — and the market's verdict came quickly: within weeks UiPath priced its IPO at $56 per share, above its target range, valuing it near $29B, roughly triple its last private mark.
First-order effects
- The S-1 puts UiPath's full financials under SEC scrutiny, forcing the RPA category leader to defend an 81%-growth, money-losing model to public investors rather than private ones.
Second-order effects
- The near-triple jump from the $10.2B private valuation to the ~$29B listing gives every late-stage automation startup a fresh comparable — and gives incumbents' M&A teams a new price floor for RPA assets.
Third-order effects
The trend: Enterprise automation vendors are crossing from venture-funded hypergrowth into public-market discipline, where each quarter's deceleration resets the multiple the whole RPA category can command.